You are here: Home » Companies » News
Business Standard

Lupin to launch sleep disorder drug in US

US business contributes over 40 per cent to the company revenue

Aneesh Phadnis  |  Mumbai: 

Lupin to launch sleep disorder drug in US

is launching generic version of Nuvigil tablets in the market. The brand has an annual market size of $515 million and is the third company to launch the generic version in the US.

On Tuesday announced it had received the Food and Administration department's final approval for the product and is launching the product shortly. The product was filed from the company's Goa plant which recently received clearance from the regulator.

business contributes over 40 per cent to the company revenue. In the first half, the business grew to 78 per cent to Rs 4,186 crore on a year on year basis. The results include the contribution of firm Gavis which the company acquired earlier this year.

has so far launched five products in the market in current fiscal and has received 16 product approvals in the same period.

RECOMMENDED FOR YOU

Lupin to launch sleep disorder drug in US

US business contributes over 40 per cent to the company revenue

US business contributes over 40 per cent to the company revenue

is launching generic version of Nuvigil tablets in the market. The brand has an annual market size of $515 million and is the third company to launch the generic version in the US.

On Tuesday announced it had received the Food and Administration department's final approval for the product and is launching the product shortly. The product was filed from the company's Goa plant which recently received clearance from the regulator.

business contributes over 40 per cent to the company revenue. In the first half, the business grew to 78 per cent to Rs 4,186 crore on a year on year basis. The results include the contribution of firm Gavis which the company acquired earlier this year.

has so far launched five products in the market in current fiscal and has received 16 product approvals in the same period.

image
Business Standard
177 22

Lupin to launch sleep disorder drug in US

US business contributes over 40 per cent to the company revenue

is launching generic version of Nuvigil tablets in the market. The brand has an annual market size of $515 million and is the third company to launch the generic version in the US.

On Tuesday announced it had received the Food and Administration department's final approval for the product and is launching the product shortly. The product was filed from the company's Goa plant which recently received clearance from the regulator.

business contributes over 40 per cent to the company revenue. In the first half, the business grew to 78 per cent to Rs 4,186 crore on a year on year basis. The results include the contribution of firm Gavis which the company acquired earlier this year.

has so far launched five products in the market in current fiscal and has received 16 product approvals in the same period.

image
Business Standard
177 22